How many clinical trials are tracked for Iron overload?

12 trials are tracked, 0 with published results.

Mode

All Oncology Infectious Disease Neurology Psychiatry Cardiology Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Anesthesiology & Pain Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Emergency Medicine Urology Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Iron overload

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Iron overload

12 trials tracked for Iron overload: 5 in phase 3 or 4.

12Trials tracked

5Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 4 4 Phase 3 1 Phase 2 5 Other / NA 2

Phase 4 Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis Completed
Phase 4 Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients Completed
Phase 4 Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children Completed
Phase 4 Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) Completed
Phase 3 Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients Completed
Phase 2 Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload Completed

Show 6 more trials

Phase 2 Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients Completed
Phase 2 Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients Completed
Phase 2 Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis Completed
Phase 2 Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Completed
N/A Non-invasive Quantification of Liver Iron With MRI Completed
N/A Massive Iron Deposit Assessment Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.